Professional Interim Management

is foremost a modern HR-Tool, not only for emergencies

Capricorn Consilium stands for quick and efficient Solutions

CAPRICORN CONSILIUM – Interim Management in Life Science

Capricorn Consilium GmbH (Ltd.) has been founded in 2009 in Vienna, Austria, as Capricorn Biotech Consulting. The high acceptance of services led to the extension beyond biotechnology. Consulting was complemented by selected interim management engagements in Business Development as well as Board Member. Early 2014, the portfolio of services has been amended by the placement of Interim Managers for Life Science companies. To reflect such changes and adopt the firm accordingly, the rebranding in Capricorn Consilium GmbH (Ltd.) took place simultaneously.

For consulting, Capricorn Consilium’s clients may be found across Europe.  For the placement of Interim Managers, the focus is Austria followed by its neighbouring countries Germany, Slovak Republic and Switzerland.

Own resources are usually taken into account for the consulting of life science companies for matters of strategy, business development, strategic partnering and funding. The existing network allows to involve a variety of experts depending on the nature of the task and teams may be formed as needed to fulfil a specific task.

For the placement of interim managers, Capricorn Consilium has chosen to become senior partner of ZMM Zeitmanager München GmbH (Ltd.).

Since more than 20 years, ZMM is specialised in the placement of interim managers in the so called DACH region Germany, Austria and Switzerland. ZMM’s pool of potential candidates comprises app. 3.000 highly skilled and qualified managers. The aspiration is to present up to 3 appropriate candidates within 48 hours.

For more information please visit the appropriate pages or the company presentation. Or call +43 676 930 3370 or send a message to

Best wishes, Martin

Themis - Funding

Valneva - Building International Sales Structures

Injectable Drugs and Infusion Technologies

AVIR Greenhills - Partnering China, Board member

Intranasal Influenza Vaccine

Crucell - Life Cycle Management

Biopharmaceuticals - Vaccines and Antibodies

Esteve - Market Entrance Study

Pharmaceuticals, API, Vaccines

European Investment Bank - Consulting


OncoQR ML - Funding

Cancer Treatment - Vaccines

Redbiotec - Business Development

Vaccines - Virus-like Particles (VLPs) - Protein Assemblies for mAb Development

S-TARget - Funding

Treatment of Allergies - Vaccines

Talecris - Market Entrance Study

Protein Therapies, Plasma Products

Themis - Strategic Partnership

Vaccines against Infectious Diseases

Otto Bock - Turnaround Project Leader

Medical Technology, Rehabilitation

Omega Diagnostics - General Manager

Immunoassay, in-vitro diagnostics (IVD)

Hospira - CFO

Injectable Drugs and Infusion Technologies

Outstanding Expertise in

Interim Management - Pharma/Biotech/MedTech – D-A-CH Region (Germany, Austria, Switzerland)

  • High consultation expertise due to more than 30 years of work as Life Science Executive
  • More than 3.000 Executives in our interim manager pool
  • Appropriate candidates get recommended within 48 hours

Vaccines - General Management - Business Development - Strategic Partnering - Commercial Operations – Funding

  • More than 30 years of track record in vaccines: General Management, Business Development, Strategic Partnering, Commercial Operations, Logistics
  • Distinct business network in vaccines and adjacent industries